Chen‐Hsuan Wu

1.4k total citations · 1 hit paper
49 papers, 972 citations indexed

About

Chen‐Hsuan Wu is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Surgery. According to data from OpenAlex, Chen‐Hsuan Wu has authored 49 papers receiving a total of 972 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Reproductive Medicine, 18 papers in Obstetrics and Gynecology and 11 papers in Surgery. Recurrent topics in Chen‐Hsuan Wu's work include Ovarian cancer diagnosis and treatment (18 papers), Endometrial and Cervical Cancer Treatments (17 papers) and Endometriosis Research and Treatment (5 papers). Chen‐Hsuan Wu is often cited by papers focused on Ovarian cancer diagnosis and treatment (18 papers), Endometrial and Cervical Cancer Treatments (17 papers) and Endometriosis Research and Treatment (5 papers). Chen‐Hsuan Wu collaborates with scholars based in Taiwan, United States and South Africa. Chen‐Hsuan Wu's co-authors include Hao Lin, Yu‐Che Ou, MC Lin, W. Li, Linlin Pan, Ilonka Evans, Helge Stalsberg, C. J. Allison, D. B. Thomas and Wenyu Wang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Applied Physics Letters and JNCI Journal of the National Cancer Institute.

In The Last Decade

Chen‐Hsuan Wu

44 papers receiving 909 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Randomized Trial of Breast Self-Examination in Shanghai: Final Results

2002 515 citations D. B. Thomas, Di Gao et al. JNCI Journal of the National Cancer Institute profile →

Peers

Countries citing papers authored by Chen‐Hsuan Wu

Since Specialization

Citations

This map shows the geographic impact of Chen‐Hsuan Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chen‐Hsuan Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chen‐Hsuan Wu more than expected).

Fields of papers citing papers by Chen‐Hsuan Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chen‐Hsuan Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chen‐Hsuan Wu. The network helps show where Chen‐Hsuan Wu may publish in the future.

Co-authorship network of co-authors of Chen‐Hsuan Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Chen‐Hsuan Wu. A scholar is included among the top collaborators of Chen‐Hsuan Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chen‐Hsuan Wu. Chen‐Hsuan Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Prevalence of homologous recombination deficiency among women with newly diagnosed ovarian, primary peritoneal, and/or fallopian tube cancer: the international HALO study 2025 ·International Journal of Gynecological Cancer ·(unknown), (unknown), (unknown), (unknown), Jooyeon Lee, (unknown), Alexandra Tyulyandina, (unknown), Chen‐Hsuan Wu	0
2	Molecular subtyping and the 2023 FIGO staging in endometrial cancer: Redefining adjuvant therapy 2025 ·Taiwanese Journal of Obstetrics and Gynecology ·Hao Lin, Yu‐Che Ou, Hung‐Chun Fu, Szu‐Wei Huang, Chen‐Hsuan Wu, Chan‐Chao ChangChien	1
3	Recent advances in cervical cancer treatment: Innovations from early-stage to advanced disease 2025 ·Taiwanese Journal of Obstetrics and Gynecology ·(unknown), Chen‐Hsuan Wu, Hung‐Chun Fu, Yu‐Che Ou	2
4	A comparative analysis of MMR immunohistochemistry panels: Evaluating the utility of four-protein versus two-protein panels in endometrial cancer patients 2024 ·Journal of the Formosan Medical Association ·Yu-Sheng Huang, Yu‐Che Ou, Chen‐Hsuan Wu, Jui Lan, Chao‐Cheng Huang, Hung‐Chun Fu, Szu‐Wei Huang, (unknown), Shaochi Wang, Hao Lin	0
5	How Progesterone Receptor Expression Impacts Platinum Sensitivity in Ovarian Clear Cell Carcinoma: Insights from Clinical and Experimental Perspectives 2024 ·International Journal of Molecular Sciences ·Chen‐Hsuan Wu, Hung‐Chun Fu, Yu‐Che Ou, I‐Chieh Chuang, Jui Lan, Ming‐Yu Yang, Hao Lin	1
6	Pretreatment carcinoembryonic antigen combined with cancer antigen-125 for predicting lymph node metastasis in endometrial carcinoma: a retrospective cohort study 2023 ·Journal of Cancer Research and Clinical Oncology ·(unknown), Hung‐Chun Fu, Chen‐Hsuan Wu, (unknown), Yu‐Che Ou, Ching‐Chou Tsai, Ying‐Yi Chen, Szu‐Wei Huang, Yingwen Wang, Hao Lin	2
7	Endometrial Cancer Detection Using a Cervical DNA Methylation Assay (MPap) in Women with Abnormal Uterine Bleeding: A Multicenter Hospital-Based Validation Study 2022 ·Cancers ·Kuo‐Chang Wen, Rui Huang, Lin‐Yu Chen, Tzu-I Wu, Chien‐Hsing Lu, Tang‐Yuan Chu, Yu‐Che Ou, Chen‐Hsuan Wu, Shih‐Tien Hsu, Dah‐Ching Ding, (unknown), Chien‐Wen Chen, (unknown), (unknown), (unknown), Yu‐Chun Weng, Po‐Hsuan Su, Hao Lin, Hung-Cheng Lai	9
8	Rare live birth to a 48-year-old woman after embryo transfer with autologous oocyte: A case report 2022 ·Taiwanese Journal of Obstetrics and Gynecology ·(unknown), Horng‐Der Tsai, (unknown), (unknown), Yujing Chen, Hsin‐Hung Wu, Chen‐Hsuan Wu	2
9	Case report: Durable response after pembrolizumab in combination with radiation - induced abscopal effect in platinum - refractory metastatic endometrial clear cell carcinoma 2022 ·Frontiers in Immunology ·(unknown), Chien-Ting Liu, Hao Lin, Yung‐Cheng Huang, Jui Lan, Yu‐Che Ou, Hung‐Chun Fu, Chen‐Hsuan Wu	5
10	Delta-like 1 homologue promotes tumorigenesis and epithelial-mesenchymal transition of ovarian high-grade serous carcinoma through activation of Notch signaling 2019 ·Oncogene ·Chao‐Cheng Huang, (unknown), Chen‐Hsuan Wu, Wenyuan Li, (unknown), Mei‐Lang Kung, Tian‐Huei Chu, Shih‐Tsung Huang, (unknown), Shih‐Chung Huang, Ming‐Hong Tai	34
11	Lenvatinib acts as the salvage therapy for advanced hepatocellular carcinoma 2018 ·Annals of Oncology ·(unknown), Yu‐Li Su, (unknown), (unknown), (unknown), Tai‐Jan Chiu, Sung‐Nan Pei, Chen‐Hsuan Wu, (unknown)	2
12	Difficulty in diagnosis and different prognoses between colorectal cancer with ovarian metastasis and advanced ovarian cancer: An empirical study of different surgical adoptions 2017 ·Taiwanese Journal of Obstetrics and Gynecology ·Ko‐Chao Lee, Hao Lin, Chan‐Chao ChangChien, Hung‐Chun Fu, Ching‐Chou Tsai, Chen‐Hsuan Wu, Yu‐Che Ou	12
13	High Immunohistochemical Expression of TGF-β1 Predicts a Poor Prognosis in Cervical Cancer Patients who Harbor Enriched Endoglin Microvessel Density 2012 ·International Journal of Gynecological Pathology ·Hao Lin, Chao‐Cheng Huang, Yu‐Che Ou, Eng‐Yen Huang, Chan‐Chao ChangChien, Chih-Wen Tseng, Hung‐Chun Fu, Chen‐Hsuan Wu, Chia‐Jung Li, Yen-Ying Ma	25
14	Disseminated peritoneal tuberculosis simulating advanced ovarian cancer: A retrospective study of 17 cases 2011 ·Taiwanese Journal of Obstetrics and Gynecology ·Chen‐Hsuan Wu, Chan‐Chao ChangChien, Chih-Wen Tseng, (unknown), Yu‐Che Ou, Hao Lin	24
15	Mortality from breast, endometrial and ovarian cancers among grand multiparous women in Taiwan 2011 ·Australian and New Zealand Journal of Obstetrics and Gynaecology ·Te‐Fu Chan, Chen‐Hsuan Wu, Chan‐Chao ChangChien, Chun‐Yuh Yang	7
16	The Positive Correlation between Cord Serum Retinol-Binding Protein 4 Concentrations and Fetal Growth 2011 ·Gynecologic and Obstetric Investigation ·Te‐Fu Chan, (unknown), Chen‐Hsuan Wu, Chien‐Hung Lee, (unknown), (unknown)	10
17	Parity, age at first birth, and risk of death from liver cancer: Evidence from a cohort in Taiwan 2010 ·Journal of Gastroenterology and Hepatology ·Chen‐Hsuan Wu, Te‐Fu Chan, Chan‐Chao ChangChien, Chun‐Yuh Yang	17
18	A Case-Control Study of Risk Factors for Fibrocystic Breast Conditions: Shanghai Nutrition and Breast Disease Study, China, 1995-2000 2004 ·American Journal of Epidemiology ·Chen‐Hsuan Wu	36
19	Randomized Trial of Breast Self-Examination in Shanghai: Final Results breakdown → 2002 ·JNCI Journal of the National Cancer Institute ·D. B. Thomas, Di Gao, Roberta M. Ray, Wenyu Wang, C. J. Allison, (unknown), Peggy L. Porter, Yang‐Yang Hu, Gengli Zhao, Linlin Pan, W. Li, Chen‐Hsuan Wu, (unknown), Ilonka Evans, MC Lin, Helge Stalsberg, Steven G. Self	515
20	The Promoter Region of the CTLA4 Gene is Associated with Type 1 Diabetes Mellitus 2001 ·Journal of Pediatric Endocrinology and Metabolism ·(unknown), Fu‐Sung Lo, (unknown), (unknown), Chunhui Huang, Hsin‐Fu Liu, Chen‐Hsuan Wu, (unknown), Jan‐Gowth Chang	24

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact